Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
Martin E Brown, Rif S El-Mallakh1Department of Neurology, 2Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USAAbstract: Eslicarbazepine is a new dibenzazepine antiepileptic agent. It is a high affinity antagonist of the voltage-gat...
Saved in:
Main Authors: | Martin E Brown (Author), Rif S El-Mallakh (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
by: Sunkaraneni S, et al.
Published: (2017) -
Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
by: Donger Zhang, et al.
Published: (2021) -
Social cognition and prefrontal cognitive function in patients with epilepsy treated with eslicarbazepine acetate
by: Laura Abraira, et al.
Published: (2017) -
Clinical utility of adjunctive retigabine in partial onset seizures in adults
by: Rejdak K, et al.
Published: (2012) -
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014)